Listeners Club

Forgot Password

Not a Member? Sign up here!

Health News

Widely used antidepressant outperformed by 3 other drugs in major study of 30,000 people

Three antidepressants may work better than fluoxetine, widely known by the brand name Prozac, at helping people with depression get better and stay well over time, a new study suggests.

The research, published in The Lancet Psychiatry, compared 20 antidepressants to determine how well they eased depression symptoms and helped prevent them from returning over time.

Researchers analyzed 115 previous clinical trials involving more than 30,000 people, according to a news release from Radboud University Medical Center in the Netherlands.

CERTAIN SLEEP HABITS COULD OFFER CLUES TO HIDDEN TYPE OF DEPRESSION, SCIENTISTS SAY

They found that escitalopram, sold under the brand name Lexapro; duloxetine, sold as Cymbalta; and agomelatine performed better over the long term than fluoxetine, which researchers used as the main comparison drug.

Eli Lilly told Fox News Digital that it discontinued manufacturing Prozac in 2024. The company noted that fluoxetine remains available in many FDA-approved generic medicines and that neither the study nor the university’s news release specifically referred to Prozac or any Lilly product.

The findings suggest that antidepressants can continue helping people after their symptoms improve, although some medications appeared to work better than others at keeping patients well.

Paul van Haaren, a researcher at Radboud University Medical Center who worked on the study, noted that the three medications have different benefits and drawbacks.

CLICK HERE FOR MORE HEALTH STORIES

"Escitalopram is already widely used," he said in the release. "Agomelatine works well, but one of its side effects is the risk of liver failure. Duloxetine is less well-known and is prescribed less frequently as a first-line treatment."

Escitalopram belongs to a common group of antidepressants known as selective serotonin reuptake inhibitors, or SSRIs. These medications are often recommended as a first option for treating depression, according to the release.

Among the SSRIs included in the study, escitalopram appeared to work best at helping patients stay well over time.

Eric Ruhé, a professor of difficult-to-treat depression at Radboud University Medical Center, said the findings could eventually influence how doctors choose antidepressants. Still, the researchers stressed that this does not mean everyone with depression should take escitalopram.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"As a prescriber, you consider the balance between a medication's benefits and side effects," Ruhé said in the release. "That balance differs from person to person."

Dr. Carole Lieberman, a board-certified psychiatrist based in Beverly Hills, California, who was not involved in the study, urged caution when interpreting the findings.

She noted that agomelatine is not approved in the U.S.

"The best way to treat someone with depression is not always with antidepressants, and certainly not with antidepressants alone," Lieberman told Fox News Digital.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Psychotherapy or talk therapy can also play an important role in treating depression, according to Lieberman, while some patients may benefit from using medication along with therapy.

There were some limitations to the study, the researchers acknowledged.

Rather than enrolling a new group of patients and following them over time, the researchers combined results from 115 previous clinical trials to compare how the medications performed.

The findings also cannot predict which antidepressant will work best for a specific person. The researchers stressed that doctors and patients should consider both the potential benefits and side effects when choosing a medication.

People with questions about their antidepressants should speak with their doctor before making any medication changes, according to the release.

Fox News Digital reached out to the researchers and additional drug manufacturers for comment.


Woman’s kratom addiction spiraled from 4 capsules to 100 a day: ‘Zombie shell of myself’

Kratom-related reports to U.S. poison centers rose about 1,200% from 2015 to 2025, reaching a record high of 3,434 last year, according to the Centers for Disease Control and Prevention.

For Hilary Tesluck, a 30-year-old woman in Michigan, the potential for addiction began well before those numbers emerged.

Tesluck, who now works to raise awareness of kratom addiction and support others in recovery, said she first tried kratom capsules in 2017 at age 21.

KRATOM INDUSTRY WARNS SYNTHETIC OPIOIDS SHOULD NOT BE CALLED 'KRATOM'

Her initial use involved leaf kratom rather than concentrated 7-OH products, she shared. The American Kratom Association argues that 7-OH should be distinguished from natural leaf kratom, while acknowledging that kratom itself can cause dependence.

"It was introduced to me by a friend who knew that I was someone who suffered from anxiety and took prescription medication for it," Tesluck told Fox News Digital. "I wanted to be more holistic and natural in what I was consuming."

She noted that she doesn’t recall any dosing recommendations on the label. "I didn’t know how much to take, but my friend told me to take four capsules."

WHAT IS KRATOM? RISKS OF POPULAR SUBSTANCE REVEALED AFTER COLLEGE STUDENTS' DEATHS

At first, Tesluck – an undergraduate student at the time, who was also conducting research and tutoring – noticed the substance gave her a boost in energy, confidence and productivity.

Tesluck's daily intake climbed gradually. "Very slowly, over time, I had to take just one more capsule or just one more dose, and then went all the way up to 100," she said.

Her day-to-day functioning began to suffer, she shared. "I was not doing very well at work. I was getting … written up for performance."

Physically, she had lost nearly 40 pounds and struggled to even stand in the shower "because my body was so wasted away."

Tesluck’s belief that kratom was natural and legal made her growing dependence difficult to accept, she said. 

"About a year and a half into my kratom addiction from just the leaf … I finally realized I needed to do something, and I needed help."

When she first sought treatment in 2020, Tesluck described feeling dismissed, saying that the facility’s urine test did not detect her use and that she had to explain what kratom was to the staff.

"They were confused why I was there," she said. "So I left after just a few days because I felt kind of humiliated, and I went right back to my use."

Tesluck found more help in 2021, when she attended an online recovery meeting.

"I had nothing to lose," she said. "It changed everything for me to hear other people telling my story for the first time."

After years of feeling alone in her addiction, she said, she finally felt surrounded by people who understood.

In 2023, Tesluck relapsed following her grandmother’s death. "I was just grief-stricken. She was really close to me," she said. "So I went to the smoke shop just to get a little bit of kratom, just one time."

She later experienced a separate relapse involving 7-OH, which she said followed the death of her cat and the end of a relationship on the same night.

MEN AND WOMEN WHO SMOKE MARIJUANA MAY EXPERIENCE DIFFERENT EFFECTS, STUDY SUGGESTS

7-OH, short for 7-hydroxymitragynine, occurs naturally in trace amounts in kratom. Concentrated 7-OH products contain much higher levels than the leaf itself.

The body converts some of kratom’s main active compound, mitragynine, into 7-OH, research shows. Both compounds act on opioid receptors and can contribute to dependence, according to the FDA.

"The 7-OH was very strong," Tesluck said. "I stayed on that for just a few months because of how intense it was."

She returned to her recovery group for support. "I had to take a leave of absence, and I got clean from 7-OH again with their help," she said.

Having struggled with both leaf kratom and 7-OH, Tesluck views them as closely connected. "It’s one problem at two strengths," she said.

‘SUPER-DRUG’ 10 TIMES STRONGER THAN FENTANYL LINKED TO DEATHS ACROSS MULTIPLE STATES

Mac Haddow, senior fellow on public policy for the American Kratom Association, disputed this characterization of leaf kratom and concentrated 7-OH. In comments to Fox News Digital, he argued that the body’s conversion of mitragynine into 7-OH does not produce equivalent exposure to concentrated products.

Haddow also raised the possibility that the capsules Tesluck initially consumed may have contained ingredients beyond natural leaf kratom.

Kratom rules vary widely across the country, with states taking different approaches to age restrictions, product standards and bans.

"It’s really been a patchwork," Tesluck said. "It’s different from state to state. Some states ban it, some states regulate it."

Florida, for example, prohibits selling or providing kratom products to anyone under 21.

Washington’s health department says unscheduled kratom products remain largely unregulated there, without age restrictions, labeling standards or ingredient-testing requirements.

Texas law requires kratom product labels to include directions and a recommended serving size.

Haddow also emphasized the need for consumer warnings, adding, "The American Kratom Association supports accurate labeling to warn consumers that kratom can cause dependence."

"We support stronger enforcement across the board, and excise taxes on kratom products to fund that enforcement."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

In an October interview with Fox News Digital, Haddow also backed age restrictions. "Twenty-one and up should be the only people who have access to these products," he said.

Tesluck also raised concerns about how the products are marketed, describing social media ads as looking "very harmless" or "very cool," potentially drawing consumers’ interest.

"It’s something that you might want to try just based on the marketing itself and the packaging," she warned.

Tesluck said her work regularly brings her into contact with parents grieving children whose deaths they attribute to kratom products, including in states with Kratom Consumer Protection Acts.

The FDA says no kratom drugs are approved by the agency, and that kratom cannot legally be marketed as a dietary supplement or added to conventional foods.

In December 2025, federal authorities seized approximately 73,000 concentrated 7-OH products valued at roughly $1 million from three Missouri firms, according to the FDA.

People taking kratom should pay attention to whether their use is beginning to dictate their daily routines, including planning around obtaining it or worrying about running out, Tesluck urged.

CLICK HERE FOR MORE HEALTH STORIES

"Like making sure when the smoke shop closes that you have enough time to get there," she said.

Diminished appetite, weight loss and hair loss were among the effects Tesluck experienced. Other signs of problematic kratom use may include cravings, higher consumption than intended, unsuccessful attempts to stop and continued use despite problems at work or home, according to the National Institute on Drug Abuse.

Feeling unable to miss a dose was another concern for Tesluck. "If I took less than what I was taking, I would feel even worse and sicker," she recalled. "So I was kind of stuck at that baseline with kratom."

Haddow acknowledged that consumers can develop dependence or addiction.

"Kratom can cause physical dependence, and some consumers have reported they develop addiction to kratom," he told Fox News Digital.

Feelings of sedation, numbness or irritability may also occur, Tesluck said.

"I was kind of like a zombie shell of myself overall," she said. "I wasn’t really the same person, personality-wise. I was irritable. I was mean."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Today, Tesluck describes herself as a "person in long-term recovery from both kratom and 7-OH addiction." She serves as executive director of End Kratom Addiction, a Virginia-based nonprofit that aims to raise awareness of kratom-related risks and advocates for stronger regulation.

"My advocacy looks a lot like meeting one-on-one with families … and coordinating resources for those who are still in addiction," she said.


Common blood pressure drug helps more stroke survivors reach critical health target

A low-cost medication could help stroke survivors whose blood pressure remains elevated despite treatment, a new study suggests.

The research, known as the REDUCE trial, looked at whether adding spironolactone, a medication commonly known as a water pill, could help lower blood pressure after a stroke. The findings were presented at the American Heart Association's Scientific Sessions, Nov. 6-9, 2026, in Chicago.

Participants were split into two groups. One added spironolactone to their regular treatment, while the other continued with usual post-stroke care.

SIMPLE EXERCISE DONE JUST ONCE A WEEK COULD HELP LOWER BLOOD PRESSURE

Researchers tracked the participants' blood pressure at home over the following six months to determine whether adding the medication made a difference.

After three months, the top blood pressure number was nearly eight points lower on average among people taking spironolactone compared with those receiving usual care – about 126 versus 133, the study said.

More patients taking spironolactone also reached the recommended blood pressure goal of less than 130/80. That included 52% of those taking the medication compared with 30% receiving usual care.

"Lowering blood pressure is the most important step in preventing another stroke, yet many survivors struggle to reach recommended blood pressure targets after a stroke," study co-lead author Dr. Jordana Cohen, an associate professor of medicine and epidemiology at the University of Pennsylvania, said in a news release.

CLICK HERE FOR MORE HEALTH STORIES

"When spironolactone was added to post-stroke care, we saw a meaningful drop in blood pressure that may lower the risk of future strokes and heart attacks," she added.

Dr. Alfred Joshua, a California-based board-certified emergency physician and former chief medical officer who was not involved in the research, said the findings are encouraging, but do not yet show that the medication prevents a subsequent stroke.

"We already know that controlling blood pressure lowers the risk of another stroke," Joshua told Fox News Digital. "This study measured blood pressure, so whether adding spironolactone leads to fewer repeat strokes is still an open question."

Spironolactone works by helping the body get rid of extra salt and water, which can lower blood pressure, according to the U.S. National Library of Medicine. It also causes the body to hold onto potassium, so patients taking it need to have their levels checked, the drug’s prescribing information states.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Joshua warned that high potassium is one of the main safety concerns because it can develop without symptoms. The risk can be higher for people with kidney problems and those taking certain medications or potassium supplements.

The medication can also lower blood pressure enough to cause dizziness, he added.

"If your blood pressure is still high after a stroke, bring your home readings to your clinician and ask whether this medication is a good fit," Joshua advised.

The trial ended early with 160 participants instead of the planned 200, and about 15% did not have blood pressure readings available at the three-month mark, the researchers noted.

People taking spironolactone were also taking slightly more blood pressure medications overall than those receiving usual care.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The study was not designed to determine whether spironolactone actually prevents another stroke or heart attack. Larger and longer studies are needed to answer that question, according to the researchers.

Fox News Digital reached out to the researchers for comment.


Simple salt substitute could prevent three million deaths a year worldwide, study estimates

Replacing regular table salt with a potassium-enriched alternative could prevent nearly three million deaths and more than 10 million cases of heart and kidney disease worldwide every year, according to a major study published in Nature Health.

Researchers at the Australia-based George Institute for Global Health analyzed dietary patterns and disease risks among 4.6 billion adults across 193 countries to estimate the potential benefits of the switch.

The study relied on mathematical simulations rather than a clinical trial, using estimates that can vary in accuracy, the researchers acknowledged.

HIGH SALT INTAKE LINKED TO FASTER MEMORY DECLINE IN ONE GROUP, STUDY FINDS

High blood pressure affects roughly 1.4 billion adults worldwide and is a leading cause of strokes, heart attacks and chronic kidney damage, according to the World Health Organization.

Consuming too much salt can contribute to high blood pressure, as its sodium content causes the body to retain water, increasing blood volume and putting added pressure on artery walls.

Potassium-enriched salt replaces some sodium with potassium while looking, tasting and cooking like regular salt. The swap reduces sodium intake while boosting potassium, which helps relax blood vessels and promotes the removal of excess sodium from the body, according to the researchers.

If households replaced only the salt used in home cooking and at the dining table, the model projected 1.85 million fewer deaths and 6.19 million fewer new cases of heart and kidney disease annually.

ANCIENT CHINESE MOVEMENT SHOWS PROMISE FOR REDUCING BLOOD PRESSURE AT HOME, STUDY SAYS

In another scenario, replacing salt only in restaurant meals and processed foods was projected to prevent about 1.56 million deaths and 5.46 million new disease cases annually.

In a more targeted scenario, researchers projected that switching 80% of adults with diagnosed high blood pressure to potassium-enriched household salt could prevent about 590,000 deaths worldwide each year.

The projected benefits varied by region, depending on population size and sources of dietary sodium. The largest potential benefit was seen in China, with an estimated 1.08 million deaths averted each year under full replacement. 

India followed with nearly 400,000 preventable deaths, while the U.S. could potentially avoid roughly 105,000 deaths and 492,000 new disease cases annually.

POPULAR FOOD COULD BOOST HEART HEALTH, BUT THE AMOUNT YOU NEED TO EAT MAY SURPRISE YOU

In many Asian and African countries, most dietary salt comes from home cooking, suggesting that greater awareness and access to potassium-enriched alternatives could encourage healthier habits, according to the researchers.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Broader adoption by food manufacturers and restaurants would be needed to maximize the health benefits in Western countries, where more than 70% of dietary sodium comes from processed and restaurant foods, the study suggested.

"This study shows that small changes have an enormous impact on two prominent diseases globally: cardiovascular disease and kidney disease," Dr. Nathan Goodyear of the Williams Cancer Institute in California told Fox News Digital.

Goodyear, who was not involved in the study, said the bigger take-home message is that health is "not something that we’re just born with."

"It’s something that we cultivate. It’s the environment we cultivate," he said. "And this environment influences the potential for disease harvest long before disease is diagnosed."

While the study's models suggested that the heart health benefits outweighed the risks for the overall population, experts cautioned that the substitute may not be safe for everyone.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Potassium-enriched salt substitutes can also pose risks, including hyperkalemia, a condition in which excess potassium builds up in the blood and can trigger dangerous irregular heart rhythms, according to the National Kidney Foundation.

The body normally removes excess potassium through urine, but people with advanced kidney disease or those taking certain blood pressure medications may have difficulty eliminating it.

The World Health Organization advises against potassium-enriched salt substitutes for people with kidney problems that impair potassium removal, unless recommended by a healthcare professional.

CLICK HERE FOR MORE HEALTH STORIES

"We’re constantly in medicine looking for the magic bullet in causation, magic bullet in disease treatment, [but] that does not exist," said Goodyear.

Chronic diseases such as heart disease, kidney disease, diabetes and cancer often develop over time due to multiple contributing factors, the doctor noted.

Widespread adoption could also face challenges, as potassium-enriched salt costs about twice as much as regular salt on average and would require cooperation from food manufacturers and suppliers, according to the researchers.


Millions of Americans use marijuana to sleep, but new study raises troubling questions

Marijuana may be making sleep quality worse, despite its widespread use as a sleep aid, a recent Northwestern Medicine study found.

The findings of the study, which included 1,266 participants, showed that both lifetime and recent cannabis users objectively had worse sleep quality, although they did not report their sleep to be worse.

Participants were monitored for almost 35 years, from young adulthood into middle age, with scientists tracking their use of cannabis over time.

AMERICA HITS MAJOR MARIJUANA MILESTONE AS DAILY WEED USE SURPASSES DAILY DRINKING

In middle age, participants wore a sleep monitor on their wrist for a week and filled out surveys about their sleep quality.

This allowed researchers to compare objective and subjective reports of participants’ sleep.

"Our data do not support the belief that cannabis is helpful as a sleep aid," said senior study author Mercedes R. Carnethon, Ph.D., as Northwestern Now reported.

"As cannabis becomes increasingly available and accepted, it's important to better understand its long-term associations with health behaviors such as sleep," Carnethon added.

CLICK HERE TO SIGN UP FOR OUR LIFESTYLE NEWSLETTER

Among all participants, a greater lifetime exposure to marijuana was linked to worse objective sleep quality.

Those who had a higher cannabis usage over time were generally asleep for a lower percentage of the night and experienced more sleep disruption.

Similarly, recent cannabis users were more likely to have more sleep fragmentation and lower sleep efficiency, compared to people who never used the substance.

The study also found there was a much higher chance that recent cannabis users would sleep longer than eight hours per night. 

The study discusses the differences between objective and subjective reports of sleep quality.

CLICK HERE FOR MORE LIFESTYLE NEWS

"What makes this study particularly interesting is that participants who used cannabis demonstrated objectively poorer sleep, yet their own assessments of sleep quality did not reflect those differences," Alfred Joshua, M.D., a board-certified emergency medicine physician based in California, told Fox News Digital. (He was not involved with the new study.)

"In other words, someone may believe marijuana is helping them sleep, while objective measurements suggest otherwise." 

Researchers considered multiple outside factors including age, race, sex, smoking frequency, alcohol consumption, physical activity and more.

Even with these factors taken into account, the study found a consistent correlation between cannabis use and poorer objectively measured sleep.

The mode of cannabis consumption, such as smoking versus taking edibles, was not considered.

"It is not surprising that the actual quality of sleep of these subjects, after chronic marijuana use, is poor compared to those who do not smoke marijuana because people who claim that they need to smoke marijuana before they go to sleep, in order to relax, are only kidding themselves," board-certified psychiatrist Carole Lieberman, M.D., of California told Fox News Digital. (She, too, was not affiliated with the new study.)

"It is more a psychological addiction than a physical one," she added. "They enjoy the high that they get right away, but the marijuana doesn't help them to sleep better."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"The researchers found that greater cumulative cannabis exposure was associated with reduced sleep efficiency, increased sleep fragmentation and more time spent awake after initially falling asleep," said Joshua, the board-certified emergency medicine physician. 

"These findings raise important questions about whether habitual marijuana use is a sustainable strategy for managing sleep problems," he added. 

Fox News Digital recently reported on other cannabis findings.

A study of nearly 450,000 American adults, for instance, linked cannabis use to an increased risk of stroke and cardiovascular disease.

The findings were scheduled for presentation at the American Heart Association’s Scientific Sessions 2026 in Chicago Nov. 6–9. They showed that both casual and heavy marijuana users have higher odds of heart conditions compared to non-users.

Khloe Quill of Fox News Digital contributed reporting. 


US reportedly loses longstanding measles elimination status as cases surge nationwide

The U.S. has reportedly lost its measles elimination status after 26 years, The Wall Street Journal reported Friday, citing sources familiar with the matter.

Loss of this status means measles is spreading continuously within the U.S. again, with the same chain of transmission persisting for at least 12 months, according to the Pan American Health Organization (PAHO).

PAHO had planned to announce the determination publicly on Tuesday, Nov. 17, according to KFF Health News, which separately reported the decision, citing researchers with direct knowledge of the deliberations.

WISCONSIN INFANT DIES OF MEASLES AS STATE SEES FIRST DEATH FROM DISEASE SINCE 1990

The country has held elimination status since 2000. Isolated cases and shorter outbreaks can still occur without forfeiting that status.

PAHO’s independent regional verification commission reviewed countries’ elimination status during its Nov. 10-13 meeting in Washington, D.C.

The U.S. reported 5,412 confirmed measles cases in 2026 through Nov. 12, more than double the 2,289 cases reported in all of 2025, according to the Centers for Disease Control and Prevention.

CLICK HERE FOR MORE HEALTH STORIES

Dr. Stephanie Widmer, a New York City-based emergency medicine physician and Fox News medical contributor, said the loss of measles elimination status is a "public health setback," emphasizing the danger posed by the infection.

"Measles isn’t just a childhood rash. It can cause pneumonia, brain inflammation, permanent neurological damage and death," she told Fox News Digital Saturday. 

"As an emergency physician, I can tell you these complications are not something we should ever take lightly.

AMERICAN VACCINES THAT TRANSFORMED PUBLIC HEALTH OVER 250 YEARS: 'OUTWEIGHS HARM'

"Losing elimination status doesn’t mean the vaccine stopped working," she added. "It means we no longer have enough protection in some communities to prevent sustained transmission."

The doctor emphasized that infants who are too young to be vaccinated and people with compromised immune systems are "paying the price for gaps in community immunity."

The loss of measles elimination status "signals that the virus is spreading continuously and that too many people remain unprotected," according to the American Academy of Family Physicians.

"It does not mean the MMR vaccine has stopped working," the AAFP said in a statement provided to Fox News Digital. "It means we must restore confidence in the safety and efficacy of life-saving public health tools."

Dr. Marc Siegel, Fox News senior medical analyst, said the change reflects transmission within the country.

"The result of losing this status is a recognition that not all spread is due to travel from overseas," he told Fox News Digital.

Siegel also called for bringing vaccination services directly to communities with low vaccination rates.

"I think one of the solutions here is for health authorities to send vaccine trucks and clinics to areas where vaccine noncompliance most exists," he said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Measles is highly contagious, infecting up to nine in 10 people without immunity who are close to an infected person, the CDC states. The virus can linger in the air for up to two hours after that person leaves.

Two doses of the measles, mumps and rubella (MMR) vaccine have been shown to be about 97% effective at preventing the disease.

The CDC recommends that children receive two doses of the MMR vaccine, with the first given at 12 to 15 months and the second at 4 to 6 years.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Most adults without evidence of immunity need one MMR dose, while certain higher-risk adults need two, according to the agency. People with two appropriately spaced doses generally do not need a measles booster.

"Restoring elimination status requires an organized and sustained response that includes increased support for state and local health departments, timelier surveillance and communications, clear information for families and an easier path to vaccination," the AAFP said.

Fox News Digital reached out to PAHO and the U.S. Department of Health and Human Services requesting comment.


New prostate cancer guidelines urge men to start screening at specific age

The American Cancer Society is recommending regular prostate cancer screening starting at age 50 for men at average risk under updated guidelines released Nov. 12.

The update shifts from emphasizing individual decisions about screening to explicitly recommending regular testing for eligible men.

The new guidelines call for PSA testing every two years for average-risk men, ages 50 through 69. Black men should begin annual screening at 45, regardless of family history. 

Other men with a father, brother or son diagnosed with prostate cancer should also begin at 45, with the frequency depending on their family history.

JOE BIDEN SHARES HEALTH UPDATE AFTER PROSTATE CANCER DIAGNOSIS WHILE ISSUING WARNING TO OTHERS

Men ages 70 to 74 should discuss whether to continue screening with their doctors; routine screening is not recommended at 75 and older.

Prostate cancer is the second-leading cause of cancer death among U.S. men. 

For disease that has not spread beyond the prostate or nearby areas, the five-year relative survival rate is nearly 100%, according to the American Cancer Society.

"Men think it is going to happen to someone else," Dr. Ash Tewari, chair of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai Medical Center in New York City, told Fox News.

MAN GOES TO DOCTOR TO PROVE HE’S 'IN PERFECT SHAPE'; TEST REVEALS SHOCKING DIAGNOSIS

The doctor, who has performed more than 10,000 prostate cancer operations, said the success rate of treating patients is exceedingly high, but many men still need to be nudged to get screened.

A prostate cancer screening involves a simple blood test for PSA, which measures the level of prostate-specific antigen, the protein produced by normal and cancerous cells in the prostate gland.

Under the updated guidelines, a PSA level of 3 ng/mL or higher in men younger than 70 warrants a repeat test to confirm the result. There are other explanations for higher PSA levels beyond the existence of prostate cancer, such as an enlarged prostate, inflammation or an infection.

CANCER DOCTOR REVEALS 5 HABITS THAT MAY REDUCE DISEASE RISK AND IMPROVE OUTCOMES

Screening can also identify slow-growing cancers that may never cause harm. The society recommends discussing screening’s benefits and possible harms with a healthcare provider and offering close monitoring as an initial approach for low-risk cancers.

CLICK HERE FOR MORE HEALTH STORIES

"We know how to cure 95% of them," said Tewari, referring to prostate cancer patients. "I can operate, we have developed medications … to get to them in time, my approach is very simple: Go right where they are."

To reach more men, Tewari and Mount Sinai have created mobile prostate cancer screening vehicles that are deployed in neighborhoods so men can be examined where they live.

The first bus, the Mount Sinai Robert F. Smith Mobile Prostate Cancer Screening Unit, was sent out in New York City in 2022. Last month, another bus was deployed to the Atlanta Falcons-Chicago Bears game at Mercedes-Benz Stadium in Atlanta. 

The Winship Cancer Institute at Emory University offered free screenings in partnership with the Atlanta Falcons during the game.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Tewari and Mount Sinai are engaged in other ways to get the word out to men.

Last month, actress Brooke Shields joined Tewari and directed a public service announcement advocating screening and early detection. The goal is to screen more than one million men for prostate cancer under Tewari's Million Strong Men Initiative.

"We need to be able to talk about ...down there," a son says to his father in the PSA video.

"I never got to have the talk with my dad early enough," Shields said in the video. Her father, Frank, died of prostate cancer in 2003 at age 61.

"Prostate cancer is treatable when detected early."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"Prostate cancer is often a disease that families don't talk about until there is a reason to," said Tewari. "We want to change that. Starting the conversation early can give men an opportunity to learn about their risk, talk with their doctors about screening and act when appropriate."

Prostate cancer is one of the most common cancers in men. The ACS estimates that more than 333,000 men in the U.S. will be diagnosed in 2026, and about 36,000 will die from the disease.


Stroke survivors get FDA-approved daily pill shown to cut repeat risk by 26%

The FDA has approved Sunharbo (asundexian) to reduce the risks of a recurring stroke in some adults.

The medication is taken as one 50 mg pill each day, along with standard blood clot-preventing medicine, such as aspirin.

It is designed to lower the risk of another stroke in adults who recently had a stroke caused by a blood clot (not a heart-related clot) or a mini-stroke (transient ischemic attack, or TIA), which is a temporary interruption of blood flow to the brain, according to the FDA release.

HEALTHY RUNNER SUFFERS SUDDEN STROKE AT 27 AS DOCTORS DISCOVER POSSIBLE CAUSE

Sunharbo is the first medication of its kind to block a specific protein in the blood (factor XIa) that helps blood clots form.

"This blocks a very specific protein that’s part of the cascade of blood clotting," Dr. Richard Kovacs, a cardiologist at Indiana University School of Medicine and chief medical officer of the American College of Cardiology, told Fox News Digital.

Approval followed a Phase 3 randomized trial involving 12,327 patients across 37 countries, all of whom had a recent non-cardioembolic ischemic stroke or high-risk TIA.

Among those who took 50 mg of asundexian orally once daily, plus antiplatelet therapy for a period of 14.2 months, there was a 26% relative reduction in ischemic stroke compared to groups who took a placebo along with antiplatelet therapy.

COMMON HEART PILL UNDER SCRUTINY FOR OLDER PATIENTS AS STUDY WEIGHS RISKS OF STOPPING

Although there was not a significant overall increase in major bleeding, the risk of that side effect was higher in certain subgroups. However, gastrointestinal bleeding was more common with asundexian, and major bleeding was increased among patients older than 75 during the first 90 days.

Patients who took asundexian also had a lower risk of stroke, heart attack or death compared with those who received a placebo.

About 6.6% of patients taking asundexian experienced a stroke, compared with 8.8% in the placebo group.

"So, it doesn’t completely eliminate the risk of a second stroke," Kovacs said.

EVEN OCCASIONAL MARIJUANA USE LINKED TO HIGHER STROKE RISK, STUDY FINDS

The risk of death from heart-related causes, heart attack or stroke was also lower among patients taking asundexian (9.2% versus 11.1%).

Similarly, 10.5% of patients taking the medication experienced death from any cause, compared with 12.3% of those receiving a placebo.

The findings were published in The New England Journal of Medicine Nov. 9.

The trial, which was funded by Bayer, the manufacturer of asundexian, had several limitations.

CLICK HERE FOR MORE HEALTH STORIES

Because patients were treated for an average of about 14 months, long-term safety and effectiveness of the medication are unclear.

The study also excluded patients with certain heart conditions and those with more severe strokes.

"Importantly, this drug is not for patients who have had strokes due to atrial fibrillation or due to a valve problem in their heart," Kovacs said.

Longer-term studies are needed to identify safety and effectiveness among older patients, underrepresented populations and patients with greater stroke severity, the researchers noted.

Kovacs emphasized that patients should discuss the medication with a care team soon after a stroke.

"In the clinical trial that approved this drug, this drug was given very soon after the stroke, within 72 hours," he said. "So, it’s important to have that conversation about whether this is a drug for the patient early on, often in the hospital."

Medication is only one part of preventing another stroke, the cardiologist emphasized.

"The cause of the stroke in many of these patients was atherosclerosis," he said, describing the condition as "plaque buildup that can cause circulation problems and the lack of blood flow to the brain.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"So, it’s important for any stroke patient to do all the other things that you can do in addition to this medicine to prevent a second stroke – like stopping smoking, keeping your cholesterol low, eating healthy and, most importantly, getting exercise."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

More than 795,000 people in the U.S. have a stroke each year, including about 185,000 who have had one before, according to the CDC.

About one in four stroke survivors experiences another within five years.


Severe allergic reaction after sipping energy drink traced to unexpected source

Anaphylaxis, a severe, potentially life-threatening allergic reaction, is usually linked to peanuts or shellfish, but a recent case has brought up a new concern.

According to a report by the American College of Allergy, Asthma and Immunology (ACAAI), a teen experienced a severe allergic reaction from an energy drink.

The case, which was presented at the ACAAI’s 2026 Annual Scientific Meeting held Nov. 12–16 in Phoenix, Arizona, involved a 15-year-old boy who developed "widespread hives," wheezing and difficulty breathing after trying a new beverage.

POPULAR DRINKS LINKED TO HEART ATTACKS, CARDIAC ARREST IN YOUNG ADULTS, STUDY FINDS

The teen was reportedly taken to a hospital, where he received two doses of epinephrine; albuterol, a medication commonly used in rescue inhalers to help open the airways; an antihistamine and IV fluids. His symptoms resolved after treatment.

A review of the drink’s label revealed that it contained 5 grams of collagen derived from cod.

According to the report, the teen reported mild throat itching and lip swelling when eating canned tuna, although he had eaten salmon without an issue. He also has eczema, asthma and allergic rhinitis, commonly called hay fever.

WHY STACKING SUPPLEMENTS WITHOUT A BLOOD TEST FIRST CAN DO MORE HARM THAN GOOD

Despite the teen's symptoms, a skin prick testing for tuna, cod and flounder allergy all returned negative.

These findings represent initial research presented at the ACAAI conference and have not yet been published in a peer-reviewed journal.

Allergist Annabelle Rowland, M.D., study author and an ACAAI member based in Georgia, commented in a news release that this case shows "how tricky fish allergy can be."

"Collagen from fish is showing up in a growing number of products, from drinks to supplements," she said. "Standard fish allergy tests mostly look for a different fish protein and contain very little collagen, so a person can test negative and still react."

In a statement sent to Fox News Digital, a spokesperson for the Council for Responsible Nutrition in Washington, D.C., said that collagen ingredients can come from several animal sources, like fish, cattle and pigs.

"While collagen has been studied for potential benefits related to skin and joint health, consumers should consider their individual health needs and sensitivities when choosing products," they advised.

CLICK HERE FOR MORE HEALTH STORIES

"Fish-derived collagen can pose an allergy risk for people sensitive to fish, and processing or hydrolysis does not necessarily eliminate that risk."

The spokesperson recommended those with fish allergies carefully review product labels, which are required to identify major food allergens, such as fish. Consumers should also consult with their healthcare provider before considering these products.

"The case presented at ACAAI highlights the importance of allergen awareness, but a single suspected reaction does not establish how frequently such reactions occur," they added.

"Product manufacturers are required by law to provide accurate ingredient information and major allergen disclosures so consumers can make informed choices."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Sung Poblete, Ph.D., CEO of Virginia-based Food Allergy Research & Education, told Fox News Digital fish collagen is increasingly being used in products like supplements, beverages and wellness items.

"While many people with fish allergy avoid all finned fish, reactions can vary between individuals and between different fish-derived proteins," she said. "So, someone can be allergic to one type of fin fish and not another."

Poblete added that labels must identify the species of fish. Crustacean shellfish, such as shrimp, crab and lobster, must also be specifically identified, according to the FDA.

"For someone managing fish or shellfish allergy, 'marine collagen' on a label calls for a closer look at the ingredient list and 'contains' statement," she said. "If the source still isn’t clear, FARE encourages people to call the manufacturer before using the product."

Consumers are encouraged to ask the manufacturer what the collagen is made from, and how the product is sourced, packaged and tested for allergens.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"This case offers a timely reminder to read every label, including on drinks and supplements, and talk with an allergist about any reaction, even if a test came back negative," Poblete added.

Fox News Digital reached out to energy drink manufacturers for comment.


Widely used diabetes drug may offer unexpected health benefit

For decades, doctors have relied on metformin to help people with type 2 diabetes manage their blood sugar. Now, new research suggests the widely prescribed drug may offer benefits beyond blood sugar control.

Researchers at Stanford University found that adults with type 2 diabetes who were taking metformin before catching COVID-19 had a 39% lower risk of dying in the year following their infection than patients taking a different type of diabetes medication.

The findings, published in the journal Diabetes, Obesity and Metabolism, point to potential protective effects that go beyond basic glucose control.

POPULAR WEIGHT-LOSS DRUGS MAY PREVENT PREDIABETES FROM TURNING INTO DIABETES

High blood sugar can weaken immune defenses, according to the Centers for Disease Control and Prevention. Metformin lowers blood sugar and helps the body use insulin more effectively, though it's unclear whether these effects explain the study’s findings.

Researchers noted that the drug may help regulate a biological pathway involved in blood pressure and fluid balance that influences the severity of COVID-19. Earlier studies have also indicated that metformin can reduce inflammation and lower viral levels in the body during an active infection.

DIABETES DRUG COULD SLASH RISK OF FATAL HEART CONDITION IN ONE GROUP, SCIENTISTS REVEAL

To assess the impact on long-term survival, the team analyzed U.S. medical records for 53,332 adults with type 2 diabetes who tested positive for COVID-19 between October 2021 and November 2023.

All patients were between 30 and 85 years old and had been prescribed either metformin or another diabetes drug, known as dipeptidyl peptidase-4 inhibitor (DPP4i), at least a month before their diagnosis.

"Metformin is the first drug most people with type 2 diabetes are given. DPP-4 inhibitors usually come later, or go to people who cannot take metformin, often because they are older or have kidney disease or other health problems," Ziyad Al-Aly, M.D., a senior clinical epidemiologist at Washington University in St. Louis, told Fox News Digital.

"Put simply, people on metformin are generally healthier than people on DPP-4 inhibitors," added Al-Aly, who was not involved in the study.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Most of the group, 50,965 patients, were taking metformin, while 2,367 were taking a DPP4i. Patients on metformin were slightly younger on average, 60 years old compared with 64 for those on the alternative medication.

After adjusting for age, gender and other variables, the researchers found that patients taking metformin were more likely to survive over the following year.

The data initially suggested a 13% drop in long COVID symptoms among metformin users, though further statistical testing found no statistically significant link.

CLICK HERE FOR MORE HEALTH STORIES

The new analysis aligns with other recent research, including a study from the University of Minnesota Medical School that showed patients who were prescribed metformin within six days of a COVID-19 diagnosis were less likely to die or develop long COVID.

"There is some evidence from the same group that metformin, started early in a COVID infection, may lower the risk of long COVID, [but] that still needs to be confirmed in large, well-designed randomized trials," Al-Aly noted.

Because the Stanford review relied on existing medical records rather than a clinical trial, the authors cautioned that the study cannot prove metformin directly caused the higher survival rate.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Patients taking DPP4i medications tended to be older and had more underlying health conditions, which could have contributed to their higher mortality risk, the researchers noted.

The team also lacked complete records on patients' COVID-19 vaccination status.

"This is not enough evidence to change treatment," Al-Aly cautioned. "People take a DPP-4 inhibitor because they need it to control their diabetes, usually because metformin was not enough or was not an option for them."

"No doctor is choosing between these two drugs for the same patient. The comparison in this study is not a real choice in any clinic. If you take either drug, do not change it because of this study."


Healthy runner suffers sudden stroke at 27 as doctors discover possible cause

As stroke rates continue to rise among young adults, one Boston man is sharing his experience of a life-threatening event at just 27 years old.

Patrick Mascoli, an engineer and fitness enthusiast, was regularly running 40 miles a week at the time of his medical emergency. Beyond a history of migraines, there were no obvious symptoms or warning signs, he shared with Fox News Digital.

On a Sunday in July 2024, Mascoli went for a 10-mile run and headed to the gym for a lifting session. As he was changing alone in the locker room, something felt suddenly wrong.

STROKES NEARLY DOUBLE AMONG ADULTS UNDER A CERTAIN AGE IN DISTURBING TREND

"It just felt like a bomb went off my head," he shared with Fox News Digital. "The right side of my brain just felt like a severe burning sensation, a lot of pain. And that came out of nowhere."

At first, Mascoli assumed it was related to blood pressure-related fainting episodes he’d had when he was younger, but then his vision grew blurrier and the pain intensified.

"This wasn’t something I had ever experienced before," he said.

When Mascoli tried to stand up and step forward, his leg moved to the right instead, sending him into the wall.

"No matter what I was telling my body to do, it just wasn’t working," he said. "My legs just went in completely opposite directions of the way that I wanted them to. And my vision was a complete swirling mess."

WHAT TO DO IF SOMEONE IS HAVING A STROKE, AFTER JILL BIDEN REVEALED DEBATE-NIGHT FEARS

Mascoli managed to text his sister before collapsing again. As his sister drove to the gym, he lay on the floor, repeatedly vomiting, unable to control his legs and struggling to see.

Stroke briefly crossed his mind, he said, but his age and fitness level made him dismiss it.

"I thought a stroke was something that happens to someone who is elderly or has other pre-existing conditions," Mascoli said. "And in my mind, I’m like, ‘I don’t fit that.’"

When his sister arrived, she found Mascoli on the bathroom floor of the gym, drenched in sweat, and called 911.

First responders initially suspected dehydration because Mascoli was young, appeared healthy and had just run in the heat. He received IV fluids, but there was no improvement, he shared. Clinicians also treated him for suspected vertigo, but that didn’t relieve the symptoms.

EVEN OCCASIONAL MARIJUANA USE LINKED TO HIGHER STROKE RISK, STUDY FINDS

Clinicians at Boston Medical Center later identified the stroke on a CT scan and confirmed it with an MRI, according to Mascoli.

The next morning, Mascoli’s head pain had subsided, but he still had significant movement problems, particularly on his right side, which he described as "completely useless."

He spent a few days in the hospital, during which he slowly began walking again with the use of a walker.

The diagnosis left Mascoli fearful about his future. "It was very jarring and terrifying," he said.

Once the stroke was identified, Mascoli’s care team investigated possible causes. He underwent extensive blood testing for clotting disorders and other conditions, without clear answers.

A heart ultrasound using tiny bubbles injected into a vein revealed a patent foramen ovale (PFO) — an opening between the heart’s upper chambers that normally closes shortly after birth.

"In most people, it closes shortly after birth – but in others, it does not shut completely," Dr. Dheeraj Khurana, chief of cardiology at Episcopal Health Services in New York, told Fox News Digital. Khurana did not treat Mascoli.

"In rare cases, a blood clot passes through this opening, travels to the brain and causes a stroke," Khurana said.

Mascoli’s doctors considered the opening the likely route by which a clot reached his brain.

Most people with the opening experience no related health problems, according to the American Stroke Association.

In younger stroke patients who lack common risk factors and whose initial tests reveal no clear cause, doctors may look for a PFO using an ultrasound of the heart called an echocardiogram, Khurana said.

SILENT HEART THREAT FOUND IN ADULTS UNDER 30 WITH NO KNOWN CARDIOVASCULAR DISEASE

Mascoli does have a lingering uncertainty about why a clot formed in the first place.

"I had none of the genetic predispositions to it. I had no clear physical issues that were causing it. So that is a little bit of a mystery," he said.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

About a month after the stroke, Mascoli underwent a catheter procedure to close the opening in his heart, using an Abbott device that resembled a mesh, double-sided umbrella.

He said his cardiologist’s reassurance that the suspected pathway had been addressed helped ease his fears.

Although his mobility has improved with therapy, Mascoli said he still has lingering difficulty with fine motor skills. "I was very hard on myself, and I still get mad if my hands are shaking and my writing looks bad."

Returning to running brought its own anxiety. Before the stroke, Mascoli said he would head out for miles without tracking his distance, but afterward, he worried about getting stranded.

"I need to know how far I’m going because I don’t want to be too far away and have something happen," he recalled thinking.

During his recovery, Mascoli’s girlfriend gave him a fitness watch and encouraged him to start racing.

"It was something that kept me motivated, because I knew it was helping me both physically and mentally," he said.

In October 2026, Mascoli completed the Chicago Marathon as part of Team Abbott, representing the company that made his heart implant.

CLICK HERE FOR MORE HEALTH STORIES

After finishing, he listened to an emotional voice message from his sister, who had helped rescue him at the gym.

"She was the one who saved me, so it meant a lot to me," he said.

To others who have experienced health emergencies, Mascoli urged them to be patient with themselves and to not let the traumatic event define them, emphasizing that recovery looks different for everyone.

"Just take as many steps as you can," he said. "It might not be running a marathon. It doesn’t need to be this big thing."

Factors that may raise stroke risk in younger adults include high blood pressure, smoking, unhealthy cholesterol levels, clotting disorders, certain heart conditions and tears in the arteries supplying the brain, Khurana said.

"Younger adults with stroke may experience dizziness, altered mental status, vomiting and headaches, which they can easily mistake for exhaustion, especially after exercise or migraine," he told Fox News Digital.

"Other common symptoms include visual disturbances, speech problems, weakness, lethargy or seizures."

Dr. Sean Levchuck, chair of pediatric cardiology at St. Francis Hospital & Heart Center in New York, shared some general best practices for young adults to prevent a first stroke.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"Young, active adults should stay active and exercise. Following strenuous activity, fluid replacement is necessary," he advised.

The cardiologist also recommends avoiding smoking and tobacco products.

Anyone experiencing sudden loss of balance, vision changes, face drooping, arm weakness or difficulty speaking should call 911 immediately, regardless of age or fitness level, according to the American Stroke Association.


Highly contagious bird flu detected in Wisconsin as officials euthanize infected flock

A highly contagious strain of bird flu has struck a backyard poultry flock in Wisconsin, prompting officials to euthanize the birds amid ongoing concerns about the spread of the potentially deadly disease.

The Wisconsin Department of Agriculture, Trade and Consumer Protection (DATCP) confirmed Thursday a case of highly pathogenic avian influenza (HPAI) in a backyard poultry flock in Rusk County.

Officials did not specify how the flock became infected.

DATCP said all birds on the property were euthanized and will not enter the food system.

H5N1 BIRD FLU CONFIRMED IN AUSTRALIA FOR THE FIRST TIME, MEANING VIRUS HAS NOW REACHED EVERY CONTINENT

HPAI, a highly contagious virus that is often fatal to domestic poultry, has circulated among wild and domestic birds in North America since December 2021, according to DATCP.

The disease is caused by influenza type A viruses and can vary in severity depending on the strain and affected species.

The virus can spread through contact with infected birds, wild birds or their droppings, as well as contaminated equipment or clothing worn by people working with the animals, according to DATCP.

JD VANCE INSTALLS CUSTOM CHICKEN COOP AT NAVAL OBSERVATORY AND WILL PERSONALLY CARE FOR BIRDS

When HPAI is confirmed in a backyard poultry flock, officials may establish a 10-kilometer surveillance zone, though surrounding poultry premises would not face movement restrictions.

DATCP urged livestock owners to take precautions to protect their flocks and herds, including washing hands, disinfecting equipment, restricting access to animals and separating new additions for at least 30 days.

The agency also recommended that poultry owners keep their birds indoors when possible.


Hospital sewers may be breeding grounds for dangerous superbugs, study finds

Hospital wastewater has been shown to promote the growth of antibiotic-resistant bacteria, potentially making sewer systems hotspots for antimicrobial resistance, according to a new Swedish study published in Nature Communications.

Antibiotics taken by patients can pass through their bodies and enter hospital sewer systems, creating conditions that favor the growth of resistant bacteria.

Antibiotic resistance occurs when bacteria develop the ability to survive drugs designed to kill them, making some infections harder to treat. More than 9.3 million drug-resistant infections occur in the U.S. each year, resulting in more than 39,000 deaths, according to the CDC's 2026 Antimicrobial Resistance Threats Report.

DANGEROUS DRUG-RESISTANT FUNGUS SPREADS ACROSS US, REACHING 27 STATES

The researchers conducted a study involving wastewater from 10 hospitals and eight municipal wastewater treatment plants.

They wanted to determine whether hospital wastewater actually promoted the growth of antibiotic-resistant bacteria, rather than simply carrying resistant bacteria from patients.

First, the researchers filtered hospital wastewater to remove existing bacteria, then exposed other bacteria to the filtered water in laboratory experiments. All 10 hospital samples significantly favored the growth of E. coli strains resistant to ciprofloxacin and cefotaxime, two antibiotics used to treat bacterial infections.

None of the eight municipal wastewater samples showed the same effect.

DEATH REPORTED IN E COLI OUTBREAK LINKED TO CALIFORNIA PUMPKIN PATCH AS MORE CASES EMERGE

This suggested that something in the wastewater itself was helping antibiotic-resistant bacteria thrive, according to the researchers.

The team also placed plastic plates in sewer pipes to study bacteria growing on their surfaces. After 30 days, bacteria growing on surfaces inside the pipes were about three times as likely to be resistant to the two antibiotics as bacteria in the surrounding wastewater. This pattern was not observed in municipal sewers.

The researchers also measured antibiotic levels in the wastewater and tested whether those same concentrations helped resistant bacteria grow in laboratory experiments. They found that ciprofloxacin was a major contributor, while cefotaxime also played a role.

BEACHGOERS WARNED AFTER DEADLY 'FLESH-EATING' BACTERIA KILLS 5 IN SOUTHERN STATE

"The discovery [suggests] that hospital sewers could be a spawning ground for bacteria that are difficult to treat with antibiotics," Joakim Larsson, professor of environmental pharmacology at the University of Gothenburg and Director of Centre for Antibiotic Resistance Research, told Fox News Digital.

"Knowing where resistant bacteria are promoted — and where they are less likely to be — is crucial when deciding how resources and efforts should be allocated to limit risks for antibiotic resistance development."

The study had several limitations. All sampling sites were in Sweden, and researchers focused primarily on E. coli and a limited number of antibiotics, so the findings may not apply to all bacteria or locations.

CLICK HERE FOR MORE HEALTH STORIES

The sewer experiment lasted approximately 30 days, leaving longer-term effects unclear. The study also did not determine whether the growth of resistant bacteria in hospital sewers leads to more infections in patients or surrounding communities.

Although the study did not directly link hospital wastewater to human infections, Larsson said resistant bacteria could potentially reach people through contaminated water.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"When it rains heavily, treatment plants are typically overloaded, and release untreated or partially untreated wastewater with lots of bacteria," Larsson told Fox News Digital.

"If people get in contact with such waters, they can acquire those bacteria and then continue spreading them from person to person," he went on. "One thing that remains uncertain is how much you need to be exposed for resistant bacteria to colonize your gut or infect you."

The researchers identified two possible approaches to reducing antibiotic resistance in hospital sewers.

One involves using alternative antibiotics that are less likely to pass through patients' bodies unchanged and promote the growth of resistant bacteria in wastewater.

"But – and it is an important but – the patients’ need for antibiotics must not be compromised," Larsson said, emphasizing that equally effective alternatives may not always be available, and patients' medical needs must come first.

The second approach involves treating wastewater at hospitals to remove antibiotics that promote resistance, particularly fluoroquinolones and beta-lactams (two classes of antibiotics used to treat bacterial infections), while also removing harmful bacteria.

Larsson said treating wastewater at municipal plants would likely be less effective because antibiotic concentrations are high enough to favor resistant bacteria, primarily in hospital sewers.

Existing technologies can remove antibiotics from wastewater, but they can be costly and require additional treatment, he noted.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"When we know more about the drivers, we think it might be possible to develop technical solutions that are targeted and hopefully less expensive," Larsson added.

Fox News Digital reached out to the American Hospital Association requesting comment.


Ozempic and Zepbound users face 6 rebound risks after stopping, doctor warns

While GLP-1 medications like Ozempic, Wegovy and Zepbound have reshaped weight management and diabetes control, research shows that many patients stop taking them within a year.

Research has found that cycling off these medications can bring potential rebound risks, ranging from rapid weight regain to the loss of cardiovascular protection.

Dr. Frank Dumont, internal medicine physician and executive medical director at Virta Health in San Francisco, spoke with Fox News Digital about why patients stop taking GLP-1s, the potential risks and how to maintain progress afterward.

TYPE 2 DIABETES PATIENTS 21 TIMES MORE LIKELY TO ACHIEVE REMISSION WITH INTENSIVE LIFESTYLE CHANGES

Some patients may stop taking GLP-1 medications because of medical concerns or side effects, while others prefer not to remain on long-term medication, Dumont said.

Common side effects include nausea, vomiting, constipation and diarrhea.

"Those types of things can become troublesome enough that people actually have a hard time eating enough food to get good nourishment," he told Fox News Digital. "Working with your physician to make a decision about whether it's right for you to stay on the medicine or not is important."

Other serious side effects, like acute pancreatitis, would prompt immediate discontinuation of the drug.

4 SIMPLE HABITS CAN HELP SLOW MUSCLE LOSS AS YOU AGE, FITNESS EXPERT SAYS

"We know that's fairly rare, but if the pancreas becomes involved, that is not a good thing," Dumont said. "It can be very serious. It can even be life-threatening."

Certain GLP-1 medications carry a warning about thyroid tumors based on animal studies, though the risk in humans remains unknown.

These medications should not be used by people with a personal or family history of medullary thyroid carcinoma or a condition called multiple endocrine neoplasia syndrome type 2 (MEN 2).

Dumont outlined six potential risks patients may face after stopping a GLP-1.

The most immediate side effect patients notice after stopping a GLP-1 is the return of intense cravings and a sharp spike in appetite, often referred to as "food noise," according to Dumont.

Many patients assume they can treat GLP-1s like a short-term prescription, taking the drug to hit a target weight or blood sugar goal and then stopping, the doctor noted.

However, major medical organizations, including the American Medical Association (AMA) and the Obesity Medicine Association, classify obesity as a chronic condition that typically requires ongoing management.

"Unless you have significantly changed what you're doing in terms of the types of foods you're eating, it's likely you'll go back to the same foods you were eating before, and hunger and cravings will go up," Dumont said.

It is typical for GLP-1 users to experience weight regain after quitting, according to Dumont.

In the STEP 1 trial extension, participants regained about two-thirds of the weight they had lost within a year of stopping semaglutide and lifestyle interventions.

WEIGHT-LOSS DRUGS MAY FIGHT 7 SERIOUS HEALTH PROBLEMS BEFORE THE POUNDS EVEN COME OFF

In the SURMOUNT-4 trial for tirzepatide, patients who were switched to a placebo after 36 weeks of treatment regained more than half the weight they had lost over the following year, even while receiving diet and exercise counseling.

"That's just so devastating for people who felt like they'd finally found a solution that would work," Dumont said.

Biomarkers — which are measurable indicators of what’s happening inside the body, such as blood sugar, blood pressure and cholesterol levels — tend to improve while taking a GLP-1, which is beneficial for those with prediabetes or diabetes.

When a GLP-1 is stopped, these markers can reverse if not countered with a change in diet, according to Dumont.

Improvements in fatty liver disease may also fade after treatment stops, the doctor said.

"We know that these medications can help to decrease some of that steatotic or fatty liver disease that occurs," he noted. "And when you go off the medicine, if you go back to eating the way you did before, those numbers have a tendency to worsen."

Weight loss while taking GLP-1 medications can include a loss of muscle, raising concerns about body composition and long-term physical function, according to Dumont.

"When people take the GLP-1 medications, they lose weight, but they tend to lose both fat mass and lean muscle mass," he told Fox News Digital.

In a body-composition study of tirzepatide, about 25% of the weight lost was lean mass, which includes muscle and other nonfat tissue. The remaining 75% was fat.

Dumont expressed concern that patients who regain weight after stopping treatment may not fully replace the muscle they lost.

"So, there's a bit of a ratcheting-down effect if someone is on and off these medications, where they lose fat and muscle, stop the medicine, regain fat, go back on the medicine, and lose fat and muscle," he added.

The doctor emphasized that preserving muscle is important for metabolism, injury prevention and everyday activities.

In addition to the physical consequences, Dumont noted that stopping a weight-loss drug can take a heavy toll on mental health.

Many patients have spent years cycling through diets and programs without lasting success, often viewing GLP-1s as a final solution, according to the doctor.

When the medication isn't right for them — adding to a history of past weight-loss setbacks — experiencing a "regression on all fronts" can be "really devastating from a mental health standpoint," Dumont said.

"It can make you feel disheartened and like you don’t have the control you thought you did," he added.

An observational study published in BMJ Medicine found that adults with type 2 diabetes who stopped GLP-1 treatment had a higher risk of major cardiovascular events than those who continued. Longer periods without treatment were associated with greater risk.

Dumont noted that the stakes of stopping a GLP-1 go far beyond weight, pointing to the broader risk of losing metabolic benefits.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

While taking a GLP-1, lower inflammation and improved cholesterol and blood sugar levels help reduce the risk of major events like heart attacks and strokes, the doctor said.

"But again, if you stop the medicine and you haven't changed the way that you eat, then all of those numbers can worsen … and that can then increase the risk of those bad things happening — things that can be devastating from a life quality standpoint, but also can shorten your life," he warned.

In a separate interview with Fox News Digital, Dr. Jason Williams, an interventional radiologist-oncologist at the Williams Cancer Institute, confirmed that some GLP-1s can increase cancer risk, particularly in endocrine cancers – but these medications can also reduce inflammation and other markers that could reduce the risk of cancer.

"So, it's kind of a balance," he said. "Most [cancers] are more fed by this inflammatory pattern that may be associated with fat and other cytokines that the GLPs can help reduce."

CLICK HERE FOR MORE HEALTH STORIES

Williams, author of "The Longevity Primer," projected that the future of GLP-1s will include more flexible, individualized, "on and off" use, instead of dosing daily.

"We've been too conditioned to think that you take a medicine every day, but it's not really how things work for people," he said. "I think we have to look at things like phases and waves."

Reaching metabolic goals and making lasting lifestyle changes may help patients maintain their progress after stopping a GLP-1, according to Dumont.

"We actually have peer-reviewed published data demonstrating that you can indeed stop one of these medications when you reach your metabolic goals," he said.

The Virta-affiliated observational study examined selected patients with type 2 diabetes in a structured nutrition program, so the findings may not apply to all GLP-1 users.

The doctor recommended adopting sustainable eating habits before stopping a GLP-1.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"The GLP-1 is not the only solution," he said. "It needs to be coupled with ... a way of eating that's going to work for you for the long term that allows you to stop the medicine successfully if you need to."

Dumont recommended working with the prescribing clinician on a plan for stopping treatment and monitoring weight and blood sugar afterward.


Death reported in E coli outbreak linked to California pumpkin patch as more cases emerge

One person has died in an E. coli outbreak linked to a California pumpkin farm, San Luis Obispo County health officials confirmed Tuesday. Officials have not released the person’s age or identity.

The death follows confirmation of five cases of Shiga toxin-producing E. coli infection, potentially originating from Brookshire Farms in San Luis Obispo, according to an advisory issued by the County of San Luis Obispo Public Health Department.

"We can confirm that one individual associated with the E. coli outbreak has died. We are sharing this information with the permission of the individual’s family," Tom Cuddy, public information officer for the department, said in a statement to The Tribune of San Luis Obispo on Nov. 10.

E. COLI OUTBREAK LANDS 3 IN HOSPITAL; HEALTH OFFICIALS INVESTIGATE LINK TO PUMPKIN PATCH

"This is truly a heartbreaking development, and our thoughts are with the family and everyone affected by this outbreak. The entire team at Public Health extends our deepest condolences to the family and loved ones during this difficult time."

In a Nov. 6 statement, the health department said an additional 10 individuals who visited the farm between Oct. 16 and Oct. 26 and developed symptoms have been deemed "suspect cases." 

Tests of water, food and other samples from the farm found some bacteria, including other E. coli strains, but did not detect the strain responsible for the outbreak, officials said.

People who became ill shared possible exposures to corn cups, pumpkins, hay and water not intended for drinking, but officials could not pinpoint the source.

FDA WIDENS CYCLOSPORA OUTBREAK INVESTIGATION TO SIX MORE STATES AS CONFIRMED CASES TOP 6,000

No farm animals or petting zoos, which are known to be common sources of this type of infection, were accessible to visitors or operating at the farm.

Investigators faced several limitations, including numerous possible sources, items no longer available for testing and delays between exposure and sampling. No further environmental testing is planned, according to the report.

"Based on the findings of our investigation, we believe the risk of additional exposure associated with this incident has passed, and there is no longer an ongoing public health threat," said County Health Officer Dr. Christy Mulkerin.

"Our hearts go out to the families affected by this outbreak. We thank all those who have helped protect our community in response to this outbreak, and we encourage community members to continue practicing good handwashing and food safety to protect themselves and their families."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Typical symptoms of E. coli include cramping, severe abdominal pain, bloody diarrhea and signs of dehydration, which usually begin within three to 10 days of exposure.

Young children under 10 are typically at the highest risk for complications, which can include hemolytic uremic syndrome, a serious condition that damages blood cells and can lead to kidney failure, according to the Centers for Disease Control and Prevention.

Dr. Tyler Evans, an infectious disease physician and founder of Wellness Equity Alliance in California, warned that diarrhea can lead to dehydration and fatigue.

"The diarrhea is really the key component here, and the stomach cramps," he told Fox News Digital.

CLICK HERE FOR MORE HEALTH STORIES

Evans said younger children and older adults can be particularly vulnerable, emphasizing the need to closely watch children younger than 5.

Speaking generally about potential exposure routes in pumpkin patches, Evans said E. coli can spread when bacteria from feces reach someone’s mouth.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

He pointed to potentially contaminated food or water, animal contact and person-to-person transmission as possible transmission routes.

Evans also noted that not all E. coli bacteria cause illness. The confirmed cases in this investigation involve Shiga toxin-producing E. coli.

The health department shared the following safe practices to protect against these types of infections.

Fox News Digital reached out to the county health department for comment. Brookshire Farms previously told Fox News Digital it was reserving comment pending test results.


New weight-loss drug wipes out chronic knee pain in some patients, researchers say

An experimental weight-loss drug significantly reduced chronic knee pain and improved mobility in people with obesity and knee osteoarthritis, according to two clinical trials led by researchers at Northwestern University.

The trials, which were funded by Eli Lilly and published in The New England Journal of Medicine, evaluated retatrutide, a once-weekly injectable medication developed by Eli Lilly and Co.

Retatrutide, which is not yet FDA-approved, mimics three hormones involved in appetite and metabolism — GLP-1, GIP and glucagon — and has produced substantial weight loss in clinical trials.

WEIGHT-LOSS DRUGS MAY FIGHT 7 SERIOUS HEALTH PROBLEMS BEFORE THE POUNDS EVEN COME OFF

The late-stage trials enrolled more than 1,000 adults who were overweight or obese, did not have diabetes, and experienced painful knee osteoarthritis.

After 68 weeks in one trial and 80 weeks in the other, participants receiving the highest dose of retatrutide lost about a quarter of their body weight on average. A pooled analysis found that roughly two-thirds of those treated with the drug achieved at least a 50% drop in knee pain, compared with 38% of those receiving a placebo.

Beyond pain relief and functional gains, participants experienced reductions in blood pressure, lower blood lipid levels and decreased systemic inflammation, according to the researchers.

Gastrointestinal problems were the most common side effects, and serious adverse events were more common among participants receiving retatrutide than among those receiving placebo.

KNEE TREATMENT WITHOUT SURGERY OFFERS LASTING PAIN RELIEF FOR 80% OF ARTHRITIS PATIENTS, STUDY FINDS

Dr. Thomas J. Schnitzer, a professor at Northwestern University Feinberg School of Medicine and lead author of the study, said the findings offer therapeutic potential for specific groups of patients.

"For people who are obese, not diabetic, have radiographically confirmed knee osteoarthritis that has not progressed to bone on bone, and have consistent moderate knee pain, retatrutide treatment has the potential to result in a significant and meaningful reduction in their knee pain and improvement in their physical function while providing cardiometabolic benefit," Schnitzer told Fox News Digital.

While researchers anticipated benefits from the weight reduction, the "complete relief of knee pain" in one of every eight patients taking the drug was a surprise, Schnitzer said.

Painful knee osteoarthritis affects an estimated 15 million Americans, often turning routine activities such as standing, walking and climbing stairs into painful challenges.

YOUR FAVORITE SNACKS COULD BE QUIETLY WRECKING YOUR KNEES, NEW RESEARCH SUGGESTS

Conventional treatments include physical therapy, anti-inflammatory medications and steroid injections, which often offer only limited or temporary relief, according to the researchers.

CLICK HERE FOR MORE HEALTH STORIES

While earlier research has found that losing 5% to 10% of body weight through diet and exercise can ease knee osteoarthritis symptoms, losing more than 10% through those measures alone can be difficult, particularly when knee pain limits exercise, Schnitzer said.

Despite the study's promising outcomes, Schnitzer stressed that there were some limitations.

"People with knee OA who were not overweight or obese were not studied, and individuals who were obese and had more advanced OA were also excluded, so we have no information on them," he said.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The trials excluded patients who needed knee replacement surgery. Whether retatrutide slows osteoarthritis progression or reduces the need for future joint replacements remains unknown.

For individuals experiencing joint pain who may meet the study criteria, Schnitzer recommended discussing options with a healthcare provider.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"If someone fits the profile noted above, and they have been unsuccessful at losing weight, they should speak to their physician about the possibility of being treated with a medication that would help them lose weight, as that could also reduce their knee pain as well as provide cardiometabolic benefits," Schnitzer said.

At the same time, he emphasized that medication should not replace healthy daily habits.

"Before starting pharmacologic treatment for knee pain, people who are overweight should try diet and exercise and consider interventions such as physical therapy," Schnitzer advised.

"Also, even for people on weight-loss medications, exercise is an important part of any treatment plan to maintain as much muscle as possible."


Woman claims hospital injected wrong drug into her spine during knee surgery, leaving her unable to walk

A Nashville woman is seeking $150 million from Ascension Saint Thomas Midtown, alleging that a medication error during knee replacement surgery left her with a permanent spinal cord injury.

Linda Gilbert, who was 78 at the time of the incident, alleges that hospital staff injected the wrong drug into her spinal canal during the procedure.

A total of four surgery patients received potassium phosphate instead of the intended anesthetic, mepivacaine, on Aug. 14, according to an Aug. 21 statement published on the hospital system’s website.

ORGAN HARVESTING BEGAN WHILE PATIENTS STILL SHOWED ‘SIGNS OF LIFE,’ FEDERAL INVESTIGATION FINDS

The Nov. 6 complaint, which was provided to Fox News Digital by Gilbert’s attorney, alleges the injection severely injured her spinal cord and nerves, leaving her with incomplete paraplegia, severe weakness in both legs and the inability to walk, drive or live independently.

Gilbert also developed shock and respiratory failure requiring a ventilator, according to the filing. The lawsuit alleges that the patient’s injuries are permanent and says she remained in inpatient rehabilitation at a spinal cord injury center in Atlanta at the time it was filed.

CLICK HERE FOR MORE HEALTH STORIES

Gilbert’s lawsuit claims that staff continued using syringes from the same batch after two earlier patients reported burning pain. It also alleges medication preparation and verification failures, along with delays in treatment.

The patient is seeking $50 million in compensatory damages and $100 million in punitive damages.

Potassium phosphate is used to treat low phosphorus levels and to supply phosphorus in intravenous nutrition. Its prescribing information specifies that it must be diluted and administered through a vein.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The label warns that excessive doses or overly rapid intravenous administration can cause dangerous heart rhythms, cardiac arrest, seizures and death, according to prescribing information available on NIH’s DailyMed. Those warnings concern intravenous use, rather than injection into the spinal canal as alleged in Gilbert’s lawsuit.

In a statement published by local NBC affiliate WSMV on Nov. 9, Ascension Saint Thomas said it was aware of the complaint and was cooperating with the legal process, but could not share additional details because the case was ongoing.

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

"Our hearts remain with the four patients and families impacted by the recent medication error that occurred at Ascension Saint Thomas Midtown," the hospital wrote in a Sept. 11 statement on its website.

In a Sept. 16 update, the hospital said it was working with an independent quality consultant to "guide and verify the full scope of our corrective actions and process enhancements," adding that it remained "committed to learning from this and upholding the standards of patient safety, quality, and compassionate care."

About 790,000 total knee replacements are performed each year in the U.S., according to the American College of Rheumatology.

Most patients experience substantial pain relief and improved mobility, with only 2% reporting serious complications, the American Academy of Orthopaedic Surgeons states.

Medication safety recommendations emphasize the importance of clear labeling of drugs, including their names and concentrations, and reading the label to correctly identify each medication before administration. 

Fox News Digital reached out to Ascension Saint Thomas, Gilbert’s attorney, the Tennessee Health Facilities Commission and the Institute for Safe Medication Practices for comment.


Common heart pill under scrutiny for older patients as study weighs risks of stopping

Some older adults may be able to stop taking statins with little added risk over two years, but a new study raises concerns about longer-term safety.

That’s according to a randomized clinical trial that was presented on Nov. 7, 2026, at the American Heart Association Scientific Sessions in Chicago, and published in The New England Journal of Medicine.

Statins are prescription medications that lower LDL, or "bad," cholesterol by reducing how much cholesterol the liver makes. They are known to help reduce the risk of heart attack and stroke, according to the National Heart, Lung and Blood Institute.

COMMON CHOLESTEROL DRUG LINKED TO LOWER DEMENTIA RISK WHEN STARTED EARLY

The study — conducted by researchers from the University of Bern in Switzerland, the University of California, San Francisco, and other institutions — included 1,880 adults aged 70 years and older, all of whom were taking statins to prevent a first heart attack or stroke.

All participants had at least two chronic medical conditions, but did not have established cardiovascular disease or previous cardiovascular events. Half of the participants stopped taking statins, and the other half continued.

After two years, the added risk from stopping statins was small enough to fall within the limits researchers had set for the study. However, that did not mean stopping carried no added risk.

5 HABITS THAT COULD HELP KEEP YOU OUT OF A NURSING HOME, FROM AN ORTHOPEDIC SURGEON

Over the full follow-up, which lasted about two years for the typical participant and up to four years for some, about 13% of those assigned to stop statins had a heart attack, an ischemic stroke or died from any cause, compared with 9% assigned to continue treatment.

The study’s safety monitoring board also recommended that participants who were assigned to stop statins discuss restarting treatment with their healthcare team, according to the American College of Cardiology.

For other outcomes, the researchers found no meaningful differences between the two groups in reported quality of life, muscle pain, falls or loss of muscle mass and strength.

Dr. Christopher Kelly, a UNC Health cardiologist, emphasized that continuing statins did not worsen reported muscle pain or quality of life in the trial.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Although guidelines support lowering high cholesterol earlier in life, the benefits of continuing statins in older age are less certain, said study author Dr. Rita F. Redberg, a cardiology professor at the University of California, San Francisco, in a press release.

Earlier studies found no difference in mortality after adults 70 and older stopped statins for primary prevention, she noted.

"One study suggested quality of life improvements after stopping statins," Redberg said, adding that her team explored whether stopping was safe for older adults taking the drugs to prevent a first cardiovascular event.

The study had several limitations. About 14% of participants did not stick with their assigned treatment plan. Some who were told to stop taking statins resumed them, while others assigned to continue treatment stopped taking the drugs, according to the researchers.

The findings also may not apply to all older adults, as the study was limited to people aged 70 and older who had multiple chronic health conditions but no history of heart disease or stroke.

CLICK HERE FOR MORE HEALTH STORIES

Although some participants were followed for up to four years, the study primarily assessed outcomes over about two years. Longer follow-up is needed to determine how stopping statins affects patients over many years.

"This small, increased risk of cardiovascular events means that one cannot make a general recommendation about stopping statins in this patient population," Redberg said.

"There should be shared decision-making between the patient and the healthcare professional to know if it is appropriate for an individual to discontinue the medication. In general, however, discontinuation is safe for most people who are in this age group and without a previous CVD event."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Kelly, who was not involved in the study, noted that a healthy 70-year-old could live another 20 years, leaving questions about the effects of stopping treatment over that longer period.

The doctor also emphasized individualized decisions based on overall health and expected lifespan, noting that he "errs on the side of caution" with his own patients.

"I typically recommend that they continue taking it unless they have specific concerns about that medication, such as side effects, or if they are taking a lot of medicines, and they're just really eager to stop taking one of them."


Viral ‘heightmaxxing’ trend has teen boys taking cancer drugs to grow taller, doctors warn of risks

Medical experts are warning of a dangerous new social media trend known as "heightmaxxing," amid reports that teenagers are taking black-market cancer medications in an effort to grow taller.

Adolescents, primarily teenage boys, are reportedly turning to erdafitinib — often referred to online as "ERDA" or "Erta" — a targeted prescription drug approved to treat advanced bladder cancer.

Teenagers are reportedly experimenting with the prescription medication after encountering online discussions suggesting it could increase height.

DOCTORS WARN OF ‘LOOKSMAXXING’ DANGERS AFTER INFLUENCER’S LIVESTREAM EMERGENCY

"It’s extremely concerning that teenagers are experimenting with powerful cancer medications in an attempt to grow taller," Dr. Stephanie Widmer, a New York City-based emergency medicine physician and Fox News medical contributor, told Fox News Digital.

"These drugs were developed to treat serious medical conditions, not to enhance physical appearance, and taking them without a legitimate medical indication or physician supervision can have devastating consequences."

The drug maker, Johnson & Johnson, pushed back against the practice in a statement to Rolling Stone, emphasizing that the medication has never been approved to stimulate height growth and that its safety and effectiveness have not been established for any pediatric or adolescent use.

Medical research has documented unexpected growth spurts in children receiving erdafitinib for brain tumors. A 2024 study published in Hormone Research in Paediatrics described accelerated growth in two pediatric patients, while a separate case report documented a teenager who grew more than 5 inches during treatment but developed serious skeletal complications.

CALLOUT:

Physicians caution that these spurts do not equal healthy skeletal growth. Dr. Jessica Gray, a family physician in Lubbock, Texas, warned that forced, rapid growth can trigger dangerous structural problems, including premature growth plate damage and bone fractures.

POPULAR WEIGHT-LOSS DRUGS FACE NUMEROUS LAWSUITS OVER RARE ‘EYE STROKE’ LINKED TO VISION LOSS

The drug works by blocking specific cellular signaling pathways involved in cancer cell growth, Widmer shared during an appearance on Fox News' "America's Newsroom."

Those same pathways also play a role in bone development, which may help explain why some pediatric patients experienced unexpected growth during treatment.

Widmer noted that height is overwhelmingly governed by genetics, and biological shortcuts do not exist. Once growth plates close near the end of puberty, medications cannot reopen them, meaning older adolescents taking the compound are incurring catastrophic health hazards without any chance of gaining height, she said.

"One of the biggest concerns is that these medications can cause serious side effects, including potentially permanent vision damage, elevated phosphate levels and other metabolic abnormalities," Widmer said.

"We’re talking about adolescents whose bodies are still developing, and exposing them to these risks for a cosmetic goal is particularly troubling."

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Other warning signs and side effects linked to the medication include skeletal pain — especially in the hips or knees — as well as mouth sores, loose nails and skin disorders.

CLICK HERE FOR MORE HEALTH STORIES

The trend has also raised concerns about the influence of social media on teenagers' decisions about their health. Widmer noted that online discussions about physical appearance and self-improvement can expose young men to potentially unsafe practices that lack medical evidence.

"Parents need to understand that this goes beyond teenagers being insecure about their height," the doctor said.

"We’re talking about young people potentially obtaining prescription cancer medications and experimenting with them outside of medical supervision. If a child has concerns about their growth, that conversation belongs in a pediatrician’s office, not on an internet forum."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Doctors advise parents to watch for symptoms such as unusual joint pain or unexplained physical changes, and to speak with their children if they suspect they are using medications obtained online.

Teenagers concerned about their height or growth should consult a pediatrician before considering any medication.

"We should be encouraging teenagers to prioritize their health, not teaching them to gamble with it," Widmer said. "No amount of additional height is worth risking permanent damage to your vision or other serious and potentially unknown medical complications."


Aggressive cancer type linked to common chemical exposure in new study

Two "forever chemicals" have been associated with a higher risk of aggressive breast cancer, according to research from the National Institutes of Health (NIH).

Forever chemicals, known as PFAS, are a group of synthetic chemicals that break down extremely slowly and can build up in the environment and the human body.

PFAS have been used in nonstick cookware, upholstery and clothing, as well as some food packaging and personal care items.

CANCER RISK MAY BE HIGHER FOR PEOPLE WITH ONE PARTICULAR TYPE OF JOB

The study, published in the Journal of Clinical Oncology, found that women with higher blood levels of two types of PFAS — perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) — were more likely to develop estrogen receptor-negative (ER-negative) breast cancer.

ER-negative breast cancers tend to be "more aggressive" and have worse outcomes compared to breast cancers that respond to estrogen, according to a U.S. Department of Health and Human Services (HHS) press release.

Data was drawn from a large U.S. research project called the Sister Study, which investigated environmental and genetic factors related to breast cancer. All participants had a sister diagnosed with breast cancer at enrollment but did not have breast cancer themselves.

Researchers measured 17 PFAS in blood samples collected before diagnosis from 1,609 women who later developed breast cancer and a comparison sample of 2,269 women, then examined links between PFAS levels and breast cancer risk by tumor type.

EATING LESS OF COMMON INGREDIENT EARLY IN LIFE MAY SLASH CANCER RISK DECADES LATER

The highest PFOA exposure group had a 67% higher rate of ER-negative breast cancer. The rate was 93% higher in the highest PFOS group compared to those in the lowest group. These figures represent relative differences between groups, not an individual woman’s chance of developing breast cancer.

The researchers found no clear association between PFOA or PFOS and breast cancer overall.

"This study, along with the accompanying meta-analysis of previous studies, provides evidence that two PFAS are related to a higher ER-negative breast cancer risk," study leader Alexandra White, Ph.D., a researcher at the National Institutes of Health, told Fox News Digital.

As this study focused mainly on older PFAS chemicals that have been largely phased out, the researcher said experts know "very little" about the PFAS that are replacing them, which could serve as a limitation.

MICROPLASTICS DETECTED IN MOST HEART ATTACK PATIENTS' BLOOD IN STARTLING NEW STUDY

"They tend to be shorter-chain compounds and may be less persistent in our bodies and the environment, but we know little about how they may influence health outcomes, such as breast cancer," she said.

The findings show an association, not proof of causation, between forever chemical exposure and breast cancer risk, as the authors noted that more research is needed.

HHS Secretary Robert F. Kennedy Jr. said that "women deserve clear answers about how chemicals in their environment may affect their health," calling for further investigation.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

"Under President Trump’s leadership, we will pursue the evidence, confront environmental health risks and give women the information they need to protect their health," he said.

Medical oncologist Dr. Tiffany Troso-Sandoval, a New York City-based breast and gynecological cancer specialist who worked at Memorial Sloan Kettering for more than 25 years, also acknowledged that forever chemicals can increase cancer risk.

"Oftentimes, once you've been exposed to them, they will accumulate in your body and cause havoc, and can actually increase the risk of carcinogenic transformation of cells," she told Fox News Digital. "What was interesting about this study is that the link was found only in ER-negative breast cancers, which is a known aggressive subtype of cancer."

Few risk factors beyond genetic predispositions are known for ER-negative breast cancer, Troso-Sandoval noted, adding that "the study did not show that it increased the risk of all breast cancers in general."

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

She suggested PFAS might damage DNA or interfere with the body's ability to repair that damage or destroy cancerous cells.

While patients with ER-negative breast cancer had higher levels of these compounds in their bodies, that does not prove the chemicals caused their cancers, according to Troso-Sandoval.

First author Che-Jung Chang, Ph.D., a former research fellow at NIH and a current researcher at DLH, noted that although PFAS are "persistent" in the environment and in the human body, exposure is "potentially modifiable."

"People can take steps to reduce their exposure, and these findings could open new avenues for prevention," she said.

Troso-Sandoval recommends reviewing everyday sources of exposure to PFAS and other potentially harmful chemicals, including the following:

Her concerns about black plastic utensils involve other chemical contaminants, including flame retardants.

CLICK HERE FOR MORE HEALTH STORIES

"Try to look at the products that you are using very frequently, and those are the first ones to swap out," she advised. 

"Maybe consider cooking with stainless steel pots and pans ... I recommend not heating up any food in plastic containers, because as you heat these plastics, they tend to leach more of the compounds into our foods."

She recommends reviewing cosmetics and personal care products that may contain some of these compounds.


On Air Now

Ira on Sports
Ira on Sports
7:00pm - 8:00pm
Ira on Sports!

Margaritaville at Sea

INSTAGRAM

RIVIERA TRAVEL